Viemed Posts Record Q4 Revenue, Guides Flat Q1, Expands Lehan Payer Network
Viemed reported record Q4 2025 revenue and projects flat or down Q1 2026 due to new patient qualification standards reducing volumes. The company plans to expand Lehan acquisition’s payer network in high-reimbursement states, cross-train sales reps for breast pump and sleep products, and cut labor costs to stabilize margins.
1. Record Q4 Performance and Q1 Outlook
Viemed delivered record revenue in Q4 2025 and anticipates flat or slightly down performance in Q1 2026 due to uneven quarterly growth. The shift to updated patient qualification standards may reduce volumes for some respiratory services.
2. Expansion Strategy via Lehan Acquisition
Integration of the Lehan acquisition focuses on expanding the company’s payer network in states offering higher reimbursement rates. Technology integration for breast pump sales is underway to support this network expansion.
3. Sales Force Cross-Training Initiatives
Existing sleep representatives are being cross-trained to engage OB/GYN contacts for breast pump referrals while the core respiratory and sleep sales teams remain segmented. Training and deployment are prioritized in regions where payer agreements are already in place.
4. Margin Stability and Capacity Planning
To stabilize gross margins with a growing mix of services, Viemed will leverage scalability in G&A and technology spending and reduce labor expenses. Respiratory therapist capacity will adjust based on patient density and geographic expansion, with RT and patient volumes expected to grow in 2026.